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I. Introduction 
A. Big Data Generally 
The terms big data and big data analytics originally derive 
from the terms artificial intelligence, business intelligence, and 
business analytics; terms used in the 1950s, 1990s, and 2000s, 
respectively.1 Although some argue that big data is an ambiguous 
term used for many concepts,2 most definitions share a common 
theme, succinctly summarized as, “large pools of data that can be 
captured, communicated, aggregated, stored, and analyzed.”3 
Other definitions describe big data using four, or even five, “Vs”: 
(1) Volume—some data sets are measured in exabytes per day; (2) 
Velocity—data are collected in near real-time; (3) Variety—data 
may be images, video, text, meta-data, audio, location 
information, etc.; (4) Veracity—data are unpredictable and 
difficult to de-identify; and (5) Variability—data come in peaks 
                                                                                                     
 1. See Hsinchun Chen, Roger H. L. Chiang & Veda C. Storey, Business 
Intelligence and Analytics: From Big Data to Big Impact, 36 MIS Q. 1165, 1166 
(2012) (discussing the use of business intelligence and business analytics terms).  
 2. See Michael Schroeck et al., Analytics: The Real-World Use of Big Data, 
IBM GLOBAL BUS. SERVS. (Oct. 2012), 
https://www.ibm.com/smarterplanet/global/files/se__sv_se__intelligence__Analyt
ics_-_The_real-world_use_of_big_data.pdf (last visited Mar. 9, 2016) (“‘Big 
data’—which admittedly means many things to many people—is no longer 
confined to the realm of technology.”) (on file with the Washington and Lee Law 
Review). 
 3. James Manyika et al., Big Data: The Next Frontier for Innovation, 
Competition, and Productivity, MCKINSEY GLOBAL INSTITUTE iv (June 2011), 
http://www.mckinsey.com/insights/business_technology/big_data_the_next_front
ier_for_innovation (last visited Mar. 9, 2016) (on file with the Washington and 
Lee Law Review). 
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and valleys.4 Smart algorithms can identify and predict behavior 
of target groups and give insight into real-time events. This 
permits decision-makers to rely on evidence using big data 
instead of having to rely on intuition.5 Besides the benefits of big 
data, however, a simultaneously growing concern about use of 
(personal) data arises. According to a European Union 
commissioned report, Internet users are increasingly being 
monitored without giving personal data, through the use of 
digital cookies, electronic identifiers left on their browsers, or 
through their Internet Protocol (IP) addresses.6 Monitoring is not 
limited to the Internet, however. Mobile phones, cameras, 
payments, store loyalty cards, biometrics, interactive services, 
and social media networks can all be used to capture data and 
monitor users. Despite these serious concerns, common reason 
suggests that the benefits of big data, including those to 
manufacturing, healthcare treatment and research, 
communications, and transportation currently outweigh the 
drawbacks. 
B. Special Considerations of Health Big Data 
Privacy advocates have spent the better part of a decade 
teaching people that their data is precious, and that once it is 
online, it is online forever. As this message takes hold and users 
have finally started to limit the data they share online, big data 
initiatives are asking users to freely give up their data with no 
direct or immediate benefit.7 Without transparency of big data 
                                                                                                     
 4. Andrew McAfee & Erik Brynjolfsson, Big Data: The Management 
Revolution, HARV. BUS. REV. (Oct. 2012), https://hbr.org/2012/10/big-data-the-
management-revolution/ar (last visited Feb. 4, 2016) (on file with the 
Washington and Lee Law Review). 
 5. See id. (“We can target more-effective interventions [with Big Data], 
and can do so in areas that so far have been dominated by gut and intuition 
rather than by data and rigor.”). 
 6. See Special Eurobarometer 359: Attitudes on Data Protection and 
Electronic Identity in the European Union, EUROPEAN COMM’N (June 2011), 
http://ec.europa.eu/public_opinion/archives/ebs/ebs_359_en.pdf (last visited Mar. 
9, 2016) (“Online activities are particularly closely monitored.”) (on file with the 
Washington and Lee Law Review).  
 7. See id. (discussing the ways in which user data is collected and the 
benefits—or lack thereof—that users receive). 
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practices, users may continue reducing the data they share, 
especially health data, because they do not understand the 
collective value of their data. It is in this environment that the 
review boards of today and tomorrow must operate. 
Traditionally, internationally accepted frameworks have 
guided decision-makers and health professionals to decide what 
they should and should not do when dealing with health data.8 
This was necessary because health data has customarily 
warranted special protections.9 In the era of rapid technology 
advancement, however, previously accepted frameworks are no 
longer sufficient for three reasons. First, innovation is outpacing 
the frameworks themselves, many of which reflect the world of 
data collection decades ago. Second, health data is increasingly 
being collected outside of traditional healthcare settings. Third, 
                                                                                                     
 8. These international frameworks include: Nuremberg Code (available at 
http://www.hhs.gov/ohrp/archive/nurcode.html); The Belmont Report (available 
at http://www.hhs.gov/ohrp/humansubjects/guidance/belmont.html); WMA 
Declaration of Helsinki (available at 
http://www.wma.net/en/30publications/10policies/b3/); 
CIOMS/WHO International Ethical Guidelines from Biomedical Research 
Involving Human Subjects (available at 
http://www.recerca.uab.es/ceeah/docs/CIOMS.pdf); WHO Guidelines for Good 
Clinical Practice on Pharmaceutical Products (available at 
http://apps.who.int/medicinedocs/pdf/whozip13e/whozip13e.pdf); Council of 
Europe’s Convention for the Protection of Human Rights and Dignity of the 
Human Being with Regard to the Application of Biology and Medicine (available 
at http://www.coe.int/nl/web/conventions/full-list/-/conventions/treaty/164); 
UNESCO Universal Declaration of the Human in Genome and Human Rights 
(available at http://portal.unesco.org/en/ev.php-
URL_ID=13177&URL_DO=DO_TOPIC&URL_SECTION=201.html); WHO 
Operational Guidelines for Ethics Committees That Review Biomedical 
Research (available at 
http://www.who.int/tdr/publications/documents/ethics.pdf); EU Parliament and 
Council of the European Union Directive 2001/20/EC on the Approximation of 
the Laws, Regulations and Administrative Provisions of the Member States 
Relating to the Implementation of Good Clinical Practice in the Conduct of 
Clinical Trials on Medicinal Products for Human Use (available at 
http://ec.europa.eu/health/files/eudralex/vol-1/dir_2001_20/dir_2001_20_en.pdf); 
OECD Privacy Principles (available at http://oecdprivacy.org/); FTC Fair 
Information Practice (available at https://www.ftc.gov/reports/privacy-online-
fair-information-practices-electronic-marketplace-federal-trade-commission). 
 9. See 45 C.F.R. § 164 (2015) (outlining regulations to protect health 
data). 
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data are then shared with third parties not only for research, but 
also for commercial gain. 
The new environment in which health data are collected 
supplement traditionally crucial questions such as: “How to 
secure data and limit access?,” with new questions such as: 
“Should a software developer be held criminally responsible if a 
flaw in their software permits a malicious individual to kill 
someone by tampering with a remotely accessible insulin pump?” 
In this scenario, the insulin pump was connected to the Internet 
to permit remote control but also so its data could be shared and 
analyzed as part of a big data initiative. The benefits to the 
diabetic patient (and others) are real, but are they worth putting 
people’s lives at risk? Big data initiatives in other industries 
typically do not implicate life or death decisions with the 
frequency of health big data. 
C. Big Data Questions 
Big data brings forth a multitude of proposed benefits but 
also raises equally powerful disincentives: (1) Big data may lead 
to the creation of better tools, services, and public goods, but will 
it do so at the expense of privacy incursions and invasive 
marketing?; (2) Big data may help us understand political 
movements and online communities, but will it also be used to 
track protesters and suppress freedom of speech?; and (3) Big 
data may positively transform how we study human 
communication and culture, but will it also narrow the range of 
research options and alter what “research” means?10 Recent 
developments have raised new thought provoking questions, and 
this Article aims to discuss two of these unique questions that 
apply to the healthcare industry specifically: 
Is it ethical to control or influence user behavior through 
health big data? 
Should potentially life-saving information be shared with a 
patient who has consented to sharing data for an unrelated 
purpose?  
                                                                                                     
 10. See Danah Boyd & Kate Crawford, Critical Questions for Big Data, 15 
INFO., COMM. & SOC’Y 662, 663 (2012) (asking these questions). 
SELECTED ISSUES CONCERNING THE ETHICAL  
USE OF BIG DATA ANALYTICS 491 
II. Ethics of Controlling User Behavior 
A. What Is the Risk? 
Profiling and targeting of users through prescriptive 
analytics can start driving consumer behavior, rather than the 
other way around.11 This means that if a consumer acts upon a 
personalized offer, more refined personalized offers will follow, 
which in turn slowly blocks the consumer from making other 
choices because they are less aware of alternatives. Removing 
options from consumer consideration interferes with the principle 
of free choice. This practice may be interesting commercially, but 
ethically, it is a slippery slope. 
One example of how an awareness of data monitoring led to a 
change in user behavior occurred in the years following Edward 
Snowden’s leaks of National Security Agency (NSA) monitoring 
capabilities and activities.12 With knowledge that the NSA 
monitored user activity online, search terms for sensitive health 
keywords, such as “therapy,” decreased.13 People’s personal space 
and right to control their own actions were violated. Further 
troubling is that the consequences of this violation extended 
beyond merely avoiding certain searches to people avoiding 
searching for help with their life-threatening mental illnesses, 
affecting them and the public.14 
                                                                                                     
 11. See Frank Buytendijk & Jay Heiser, Confronting the Privacy and 
Ethical Risks of Big Data, FIN. TIMES (Sept. 24, 2013), 
http://www.ft.com/cms/s/0/105e30a4-2549-11e3-b349-
00144feab7de.html#axzz3zLchx46s (last visited Feb. 5, 2016) (“[T]he profiling 
and associated prescriptive analytics start driving customer behaviour, rather 
than the other way around.”) (on file with the Washington and Lee Law 
Review). 
 12. See id. (“One result of NSA whistleblower Edward Snowden has been 
the global surge in discussion about privacy and big data.”). 
 13. See generally Alex Marthews & Catherine Tucker, Government 
Surveillance and Internet Search Behavior (Apr. 29, 2015) (unpublished 
manuscript), 
https://papers.ssrn.com/sol3/Data_Integrity_Notice.cfm?abid=2412564 (last 
visited Mar. 9, 2016) (discussing the drop in certain search terms after the 
Snowden disclosures) (on file with author). 
 14. See generally id. (noting consequences from the reduction of certain 
searches). 
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From pedometers to light bulbs, the private sphere in which 
people are tracked and monitored is rapidly increasing.15 As the 
number and variety of Internet-enabled devices increases, 
wherein even furniture can interact with people, a slew of new 
data is created, just waiting to be mined or exploited.  
Paranoia and conspiracy theories aside, there is a possibility 
that people will become risk-averse and modify their behavior, as 
continuous monitoring leads to feelings of “creepiness.”16 Even if 
behaviors do not change, that may indicate a significant change 
in sociological norms, namely, desensitization to being monitored.  
Controlling user behavior comes in another less obvious 
form. A benefit of the big data trend for organizations and 
research institutions is that they may profit from the 
performance of medical and imaging procedures, either as it 
enables them to supply medical monitoring devices—for example, 
to monitor a patient’s vital signs after surgery—or to gain insight 
from the acquired data, which can have commercial value. They 
therefore have a financial incentive to perform procedures which 
may contribute to research but which are not medically necessary 
for the patient.17 Researchers seeking to increase their data set, 
and institutions seeking to maximize profits, may consciously or 
subconsciously influence patient behavior. By definition, 
                                                                                                     
 15. See Internet of Things: Privacy & Security in a Connected World, FED. 
TRADE COMM. (Jan. 2015), 
https://www.ftc.gov/system/files/documents/reports/federal-trade-commission-
staff-report-november-2013-workshop-entitled-internet-things-
privacy/150127iotrpt.pdf (last visited Mar. 9, 2016) (“The IoT [Internet of 
Things] explosion is already around us, in the form of wearable computers, 
smart health trackers, connected smoke detectors and light bulbs, essentially 
any other Internet-connected device that is not a mobile phone, tablet, or 
traditional computer.”) (on file with the Washington and Lee Law Review). 
 16. See Mike Gualtieri, Digital Creepiness: How Not To Spook Your 
Customers, FORRESTER (July 7, 2014), 
https://www.forrester.com/Digital+Creepiness+How+Not+To+Spook+Your+Cust
omers/fulltext/-/E-RES117347 (last visited Mar. 9, 2016) (defining creepiness as 
“[a] feeling by a customer that a digital experience offered by a company knows 
more about them than they should and is using that information in a way that 
makes the customer feel uncomfortable”) (on file with the Washington and Lee 
Law Review). 
 17. See Paul R. Helft & Christopher K. Daugherty, Are We Taking Without 
Giving in Return? The Ethics of Research-Related Biopsies and the Benefits of 
Clinical Trial Participation, 24 J. CLINICAL ONCOLOGY 4793, 4794 (2006) 
(questioning whether procedures as a part of research are always necessary).  
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unnecessary medical procedures expose patients to the 
unnecessary risks of those procedures. 
Using big data, not the needs of the patients themselves, as 
the driver to initiate medical treatment shocks the collective 
conscience of the medical field and shatters its foundations in the 
Hippocratic Oath. But what if the equation changes so that the 
patients provide informed consent—a subject to lengthy 
discussion on its own18—to the potentially superfluous procedures 
and even receive payment in exchange for their participation?19 
This gray area is the emerging domain of the ethics board. 
B. The Role of an Ethics Board 
The Privacy and Ethics Review Board (PERB) has a 
responsibility to spot the issues raised above and should aim to 
identify and mitigate risks to consumers. Before the PERB can 
meet to achieve this lofty objective, its members must be chosen. 
Members can and should come from different backgrounds with 
different motivational interests, but this means their selection 
and balance is particularly important. A big data code of ethics, 
stating the values an organization commits to upholding, unites 
the employees, contractors, and PERB members and fosters a 
more consistent and fair PERB. While involving privacy and 
ethics specialists is an obvious start, involving the primary 
groups likely to be affected by the choices being made, such as the 
consumers from whom data is collected and industry 
professionals, is also advised. Consumers should be empowered 
with the ability to review data collected about them, have an 
                                                                                                     
 18. See generally Frederik Zuiderveen Borgesius, Behavioural Sciences and 
the Regulation of Privacy on the Internet (Oct. 2014) (unpublished manuscript), 
http://papers.ssrn.com/sol3/papers.cfm?abstract_id=2513771 (last visited Mar. 9, 
2016) (discussing informed consent as a way to protect patient privacy) (on file 
with author); Unified Ethical Frame for Big Data Analysis, INFO. 
ACCOUNTABILITY FOUND. (March 2015), http://informationaccountability.org/wp-
content/uploads/IAF-Unified-Ethical-Frame.pdf (last visited Mar. 9, 2016) 
(same) (on file with the Washington and Lee Law Review). 
 19. Hugo Greenhalgh, Sell Your Own Personal Data, FIN. TIMES (Oct. 16, 
2015), http://www.ft.com/cms/s/0/8e51ecd4-7327-11e5-bdb1-e6e4767162cc.html 
(last visited Feb. 5, 2016) (on file with the Washington and Lee Law Review). 
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ability to withdraw it at any time, and should receive a clear 
benefit from sharing their data. In the scenario of unnecessary 
medical procedures, the threshold for informed consent should be 
raised, and counsel should also be consulted. 
III. Communicating Unexpected Findings to Data Subjects 
The second ethical question this Article explores is whether 
to communicate unexpected findings to data subjects. For 
example, when analysis on fetal stem cells in prenatal testing 
reveals that the mother has cancer, should she be informed of her 
condition? Should the answer depend on the religion or ethnicity 
of the patient? Consider that in Judaism, one is obligated to share 
medical information that may save a life,20 but in China, the 
cultural norm is not to inform an ill patient of bad news because 
they are thought of as a child that needs to be protected by 
avoiding upsetting news.21 
Even if a principal investigator wants to inform a data 
subject about the presence of disease, this might be difficult to do 
if the data has been de-identified in an effort to protect the 
subject. This creates a counterintuitive incentive to either not 
de-identify data, or to separately store data that would permit 
re-identification. Some may argue that the risk of loss of privacy 
for everyone in a study is worth the potential benefit of a 
subgroup of members. Unfortunately, this position may 
discourage participation and decrease the value of a study. These 
trade-offs need to be considered and acted upon accordingly. 
One compromise to the scenario presented above would be to 
provide participants with a choice to opt-in to receiving incidental 
findings. This permits participants to retain control over their 
                                                                                                     
 20. See Eliyahu Fink, Privacy and Government Snooping in Jewish Law, 
ORTHODOX UNION (June 18, 2013), https://www.ou.org/life/news-op-ed/privacy-
and-government-snooping-in-jewish-law (last visited Feb. 5, 2016) (explaining 
the obligations to save another’s life under Jewish law) (on file with the 
Washington and Lee Law Review). 
 21. See Jessica H. Muller & Brian Desmond, Cross-Cultural Medicine a 
Decade Later: Ethical Dilemmas in a Cross-Cultural Context, 157 WEST J. MED. 
323, 325 (1992) (“Because a patient is suffering already from the illness, it is 
unnecessary to make them suffer even more by discussing the reality of the 
disease.”). 
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data without impacting the security of every participant’s data 
and permits religious and ethnic preferences to be taken into 
account. It also avoids having to rely on a PERB to make this 
decision on behalf of participants. Another option to minimize 
risk is to have a third party store the re-identification 
information.  
IV. How Do Other Industries Handle Similar Ethical Issues? 
Ethical conundrums are not unique to the healthcare 
industry. One source of valuable guidance is to explore what 
other industries are doing in the face of similar challenges. For 
years, people have been asking, “Should an autonomous car 
seeking to avoid a collision swerve and hit a person or maintain 
course and risk serious injury to the driver?” What if swerving 
would hit multiple people, and the driver is alone? In the case of 
autonomous cars, these choices are programmed at the factory, in 
a vacuum, devoid of unique circumstantial inputs.22 
Pilot programs are bridging the gap between the automotive 
and health industries through car seats with health sensors that 
can be used to detect when the driver has a heart attack or is 
falling asleep. The benefits of a car that can drive its occupant to 
the hospital are indisputable, but they also raise the question of 
whether these benefits outweigh the ethical and privacy risks 
concerning misused data.  
There will never be universal agreement with the 
programmatic choices built into our cars, but developing and 
utilizing “ethics-by-design” principles—in the same vein as 
“privacy-by-design”23 principles—will at least make the decisions 
                                                                                                     
 22. See Will Knight, How To Help Self-Driving Cars Make Ethical 
Decisions, MIT TECH. REV. (July 29, 2015), 
http://www.technologyreview.com/news/539731/how-to-help-self-driving-cars-
make-ethical-decisions (last visited Feb. 5, 2015) (discussing the ethics of self-
driving cars) (on file with the Washington and Lee Law Review). 
 23. “Privacy by design” refers to the principle of building in privacy 
features or decisions into early stages of design, to avoid time-consuming fixes 
afterwards when violations occur. Introduction to PbD, INFO. & PRIVACY COMM’N 
ONT., https://www.ipc.on.ca/english/privacy/introduction-to-pbd/ (last visited 
Feb. 5, 2016) (on file with the Washington and Lee Law Review). 
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more understandable, if not more fair. Supporters of this concept 
further argue that ethical considerations should not be the 
exclusive domain of ethicists, but rather should be incorporated 
at every phase and in every aspect of design.24 Others advocate 
for the inclusion of philosophers to assist with the ethical 
investigations.25 Health big data practitioners must be equally 
forward-thinking or risk potential government regulation if their 
PERBs are ineffective. 
V. Conclusion and What’s Next? 
A. What Are the Issues We Have Not Thought About Yet? 
With the onslaught of Internet-enabled devices in the past 
few years, new questions about how to protect consumer privacy 
and how to ethically use data have arisen frequently. This rapid 
evolution requires constant innovation in how PERBs operate. 
Checklists and questionnaires are no longer sufficient to identify 
the majority of risks and concerns. PERBs must be prepared to 
innovate as quickly as the industries they seek to examine.  
B. How Will Privacy and Ethics Review Boards Need To Evolve? 
Responsible data stewardship and effective management of 
ethical and legal risks for big data initiatives can only be 
achieved with a well-designed PERB that operates nimbly and 
transparently. It must morally assess new data initiatives by 
providing a predictive and all-encompassing framework of how 
various involved stakeholder groups may respond and the 
possible moral and ethical challenges that need to be overcome. 
                                                                                                     
 24. See Laurel D. Riek & Don Howard, A Code of Ethics for the 
Human-Robot Interaction Profession (2014) (unpublished manuscript), 
http://papers.laurelriek.org/a-code-of-ethics-for-the-human-robot-interaction-
profession-riek-howard.pdf (last visited Mar. 9, 2016) (“The general public and 
professional ethicists will surely have input, but it would be best if attention to 
HRI ethics began within the practitioner community in order to facilitate the 
incorporation of ethical perspectives in every phase of HRI research, 
development, and marketing.”) (on file with author). 
 25. See Knight, supra note 22 (arguing in favor of philosopher input to the 
ethical dilemmas of self-driving cars). 
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The structure and composition of this board is the first step 
toward engaging stakeholders and fostering independence. The 
guidelines for the similarly purposed Institutional Review Boards 
(IRBs)26 are a good start, but without modification, they may fail 
in this new arena. A standard IRB, consisting of at least five 
individuals, contains: (1) at least one scientific member; (2) at 
least one non-scientific member; and (3) at least one member not 
affiliated with the organization.27 An ideal PERB builds on this 
model by including underrepresented groups needed for an 
independent and effective judgment. 
The PERB should be a stable internal body, containing 
external stakeholders involved on an as-needed basis. This is 
necessary to establish that affected parties are sufficiently 
represented and to establish that appropriate specialists are 
consulted for previously un-thought-of issues. The PERB should 
therefore include: (a) at least one lawyer (internal/external); (b) at 
least one business representative (internal); (c) at least one 
representative of a key stakeholder group, in order to safeguard 
their engagement and provide feedback in the moral deliberation 
process (external); (d) one Secretary to moderate a structured 
conversation (internal); and (e) an open seat, called “markets,” in 
which market or country representatives sit, in order to map out 
cultural or national differences in moral judgments and ways to 
reach consensus (internal/external). 
C. Final Thoughts 
Big data promises abundant opportunities for added value. 
The potential annual value of big data to Europe’s public sector 
administration was calculated to be €250 billion.28 Using big 
data, managers successfully rely on evidence, rather than 
intuition, permitting companies to predict consumer behavior and 
                                                                                                     
 26. See Institutional Review Board Guidebook, OFF. HUM. RESEARCH 
PROTECTION (1993), http://www.hhs.gov/ohrp/archive/irb/irb_guidebook.htm (last 
visited Feb. 5, 2016) (providing IRB guidelines for protecting research 
participants) (on file with the Washington and Lee Law Review). 
 27. Id. 
 28. Manyika et al., supra note 3, at preface. 
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health risks in ways previously thought impossible.29 Besides the 
undisputable benefits of big data, however, there is a 
simultaneously growing concern over the use of personal data, 
especially personal health data. 
As the examples above and elsewhere illustrate, the risks of 
big data extend beyond feelings of creepiness, to life-and-death 
situations. Whereas creepiness may be overcome by both 
educating and engaging data subjects into moral data decisions, 
giving data owners back some degree of control,30 and some other 
larger challenges need deeper consideration and discourse. 
The future of ethical use of our data depends on an evolution 
from IRBs to PERBs containing a wider variety of interested 
stakeholders and specialties. This Article is a starting point to 
facilitate internal discussions regarding the structure, purpose, 
and challenges of a PERB. Success will depend on the 
engagement of affected stakeholders and the respect and weight 
given to their opinions.31 Continuous attention to ethical concerns 
by everyone involved, not just the PERB, will strengthen the 
image of health big data and help to support realizing its full 
value.   
                                                                                                     
 29. See McAfee & Brynjolfsson, supra note 4 (explaining that businesses 
can “make better predictions and smarter decisions” using data). 
 30. Alistar, Big Data Is Our Generation’s Civil Rights Issue, and We Don’t 
Know It, SOLVE FOR INTERESTING (July 31, 2012, 12:40 PM), 
http://solveforinteresting.com/big-data-is-our-generations-civil-rights-issue-and-
we-dont-know-it/ (last visited Feb. 5, 2016) (“Data does not invade people’s lives. 
Lack of control over how it is used does.”) (on file with the Washington and Lee 
Law Review). 
 31. See generally Göran Svensson & Greg Wood, The Dynamics of Business 
Ethics: A Function of Time and Culture—Cases and Models, 41 MGMT. DECISION 
350 (2003) (providing examples of this). 
